TL1A Therapeutics in IBD [#0005] Session Title: IBD: Omics for Diagnosis, Disease Stratification and Therapy Selection Title: Omilancor Reverses Colonic Treg Depletion and Downregulation of ...

Over roughly 9 years of follow-up, people with the swallowing disorder achalasia had a 42% higher risk of mortality compared ...

The 2024 season could best be described as one of hardship and frustration for Auburn kicker Alex McPherson. He made just one appearance all year due to a lingering gastrointestinal illness, which was ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Palisade Bio (PALI) announced the completion of enrollment and dosing in all five Phase 1a SAD cohorts, all four MAD cohorts, and the food ...

OSE Immunotherapeutics to Present Groundbreaking Extension Period Data on Lusvertikimab at DDW 2025 New Clinical Data from Phase 2 Extension ...

Using vedolizumab first, before tumor necrosis factor-α inhibitors, improved quality-adjusted life-years in both ulcerative ...

The long-term incidence of MACE, VTE, and malignancies is low among patients with RA or UC receiving filgotinib, though a slight increase was observed among older patients.

This cancer moves quickly, and I was told to expect that I likely already had this cancer in multiple organs. Thankfully, a ...

Inflammatory bowel disease (IBD) is associated with increased risks for genitourinary cancers, including prostate cancer and renal cell carcinoma (RCC), according to study results presented at the ...

Community members gathered for a different kind of walk on Saturday, looking to raise awareness for two medical conditions.

Learn more about whether ACADIA Pharmaceuticals Inc. or Alvotech is a better investment based on AAII's A+ Investor grades, ...